Medline (MDLN) News
NASDAQ: MDLNHealthcareMedical Instruments & SuppliesUSD
36.26+0.52 (+1.45%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MDLN news summary
We found 27 recent headlines mentioning Medline (MDLN): 0 in the past week and 2 in the past 30 days, most often from Seeking Alpha, Nasdaq. For price context, MDLN is up 1.45% at $36.26. The most recent story, "Medline: A Tough First Year As A Public Business", was published by Seeking Alpha on Sep 16, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Medline headlines
- Medline: A Tough First Year As A Public BusinessSeeking Alpha
- Medline Inc. (MDLN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking AlphaMDLN, MS
- Medline (MDLN) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- After Hours Most Active for Aug 6, 2026 : TTD, CMCSA, AAPL, AGNC, MDLN, CPNG, NU, NVDA, RKT, HDB, AXIA, HALThe NASDAQ 100 After Hours Indicator is up 20.06 to 29,393.39. The total After hours volume is currently 159,735,774 shares traded.The following are the most active stocks for the after hours…NasdaqTTD, CMCSA, AAPL, AGNC
- Medline raises 2026 organic sales outlook to 9%-10% while lowering adjusted EBITDA to $3.3B-$3.4BSeeking Alpha
- Medline Inc. (MDLN) Q2 2026 Earnings Call TranscriptSeeking Alpha
- Medline Q2 Earnings Call HighlightsA Fresh IPO That Long-Term Investors Shouldn’t IgnoreMedline (NASDAQ:MDLN) reported second-quarter 2026 net sales growth of 12% to $7.7 billion, supported by demand across its medical-surgical…Nasdaq
- Medline Inc. 2026 Q2 - Results - Earnings Call PresentationSeeking Alpha
- Here's What Key Metrics Tell Us About Medline (MDLN) Q2 EarningsAlthough the revenue and EPS for Medline (MDLN) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street…Nasdaq
- Why Symbotic Stock Dropped 24% in the First Half of 2026 And Is a Screaming Buy NowKey PointsSymbotic recently entered the healthcare sector with a new customer.NasdaqSYM, WMT, TGT, MDLN
- Medline: After IPO In 2025, This Year Is A Bet On Continued GrowthSeeking Alpha
- ICUI or MDLN: Which Is the Better Value Stock Right Now?ICUI vs. MDLN: Which Stock Is the Better Value Option?NasdaqICUI, MDLN
- Medline Inc. (MDLN) Presents At Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking AlphaMDLN, GS
- Why Symbotic Stock Slumped 21% in May And Just Hit a 2026 LowKey PointsSymbotic is sitting on a massive backlog and recently signed a large customer.NasdaqSYM, WMT, TGT, MDLN
- Medline Inc. (MDLN) Presents at 46th Annual William Blair Growth Stock Conference TranscriptSeeking Alpha
- Medline (MDLN) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesAlthough the revenue and EPS for Medline (MDLN) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street…Nasdaq
- Medline Inc. 2026 Q1 - Results - Earnings Call PresentationSeeking Alpha
- Medline Inc. (MDLN) Q1 2026 Earnings Call TranscriptSeeking Alpha
- MDLN Gets FDA Warning for Quality Lapses in Angiographic SyringesMDLN faces FDA warning over cGMP lapses in angiographic syringes, citing weak quality controls, CAPA gaps and design flaws despite escalating share price.NasdaqGMED, PACB, BDSX, MDLN
- Medline: A Lack Of Compelling Risk-Reward Makes Me CautiousSeeking Alpha
- Medline (MDLN) Price Target Increased by 13.24% to 54.65The average one-year price target for Medline (NasdaqGS:MDLN) has been revised to $54.65 / share. This is an increase of 13.24% from the prior estimate of $48.27 dated February 21, 2026. The price…Nasdaq
- Medline Inc. (MDLN) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptSeeking AlphaMDLN, BCS
- Medline Inc. (MDLN) Q4 2025 Earnings Call TranscriptSeeking Alpha
- Medline Inc. 2025 Q4 - Results - Earnings Call PresentationSeeking Alpha
- Will Medline's Q4 Earnings Validate Its Prime Vendor Growth Strategy?MDLN is set to report first earnings as a public company, with Prime Vendor growth and brand mix in focus ahead of Q4 results.NasdaqMCK, COO, STAA, MDLN
- Tigress Financial Initiates Coverage of Medline (MDLN) with Buy RecommendationFintel reports that on February 5, 2026, Tigress Financial initiated coverage of Medline (NasdaqGS:MDLN) with a Buy recommendation. Analyst Price Forecast Suggests 2.78% UpsideNasdaq
- Symbotic Could Be a Massive Breakout Stock in 2026 After a 150% Surge in 2025Key PointsSymbotic delivered strong numbers and made some major growth moves in 2025.NasdaqSYM, WMT, MDLN